Lupus anticoagulant is frequent in patients with Covid-19

被引：1
作者：
Harzallah, Ines [1 ]
Debliquis, Agathe [1 ]
Drenou, Bernard [2 ]
机构：
[1] Grp Hosp Reg Mulhouse Sud Alsace, Lab Hematol, 20 Rue Dr Laennec, F-68070 Mulhouse, France
[2] Grp Hosp Reg Mulhouse Sud Alsace, Dept Hematol, Mulhouse, France
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2020年 / 18卷 / 08期
关键词：
D O I：
10.1111/jth.14867
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2064 / 2065
页数：2
相关论文
共 50 条
  • [21] A Case Series of Immune Flare and Lupus Anticoagulant Following COVID-19 Vaccination
    Cherabuddi, Medha Reddy
    Al-Saheli, Zaid
    Donthireddy, Vijaya
    BLOOD, 2022, 140 : 11234 - 11235
  • [22] Acute Ischemic Stroke in a Lupus Anticoagulant-Positive Woman With COVID-19
    Gemcioglu, Emin
    Erden, Abdulsamet
    Davutoglu, Mehmet
    Karabuga, Berkan
    Kucuksahin, Orhan
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 (06) : 236 - 237
  • [23] Delirium: A Frequent Manifestation in COVID-19 Older Patients
    Mattace-Raso, Francesco
    Polinder-Bos, Harmke
    Oosterwijk, Barbara
    van Bruchem-Visser, Rozemarijn
    Goudzwaard, Jeannette
    Oudshoorn, Christian
    Ziere, Gijsbertus
    Egberts, Angelique
    CLINICAL INTERVENTIONS IN AGING, 2020, 15 : 2245 - 2247
  • [24] Lupus anticoagulant associates with thrombosis in patients with COVID-19 admitted to intensive care units: A retrospective cohort study
    Noordermeer, Tessa
    Schutgens, Roger E. G.
    Visser, Chantal
    Rademaker, Emma
    de Maat, Moniek P. M.
    Jansen, A. J. Gerard
    Limper, Maarten
    Cremer, Olaf L.
    Kruip, Marieke J. H. A.
    Endeman, Henrik
    Maas, Coen
    de Laat, Bas
    Urbanus, Rolf T.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2022, 6 (06)
  • [25] A recent update of anticoagulant therapy on severe COVID-19 patients
    Rusdiana, Taofik
    Putriana, Norisca Aliza
    Husni, Patihul
    Akbar, Mohammad Rizki
    Araki, Takuya
    Subarnas, Anas
    JOURNAL OF RESEARCH IN PHARMACY, 2021, 25 (06): : 807 - 814
  • [26] Non-hospitalised COVID-19 patients have more frequent long COVID-19 symptoms
    Mohamed-Hussein, A. A. R.
    Amin, M. T.
    Makhlouf, H. A.
    Makhlouf, N. A.
    Galal, I.
    Abd-Elaal, H. K.
    Abdeltawab, D.
    Kholief, K. M. S.
    Hashem, M. K.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2021, 25 (09) : 732 - +
  • [27] Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID-19 patients
    Menezes-Rodrigues, Francisco Sandro
    Padrao Tavares, Jose Gustavo
    Pires de Oliveira, Marcelo
    Guzella de Carvalho, Rafael
    Ruggero Errante, Paolo
    Omar Taha, Murched
    Jose Fagundes, Djalma
    Caricati-Neto, Afonso
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (08) : 2073 - 2075
  • [28] Abnormal immunothrombosis and lupus anticoagulant in a catastrophic COVID-19 recalling Asherson’s syndrome
    Luca Roncati
    Lorenzo Corsi
    Giuseppe Barbolini
    Journal of Thrombosis and Thrombolysis, 2021, 52 : 1043 - 1046
  • [29] Abnormal immunothrombosis and lupus anticoagulant in a catastrophic COVID-19 recalling Asherson's syndrome
    Roncati, Luca
    Corsi, Lorenzo
    Barbolini, Giuseppe
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 52 (04) : 1043 - 1046
  • [30] Optimal Anticoagulant Dosing in Patients with COVID-19, a Retrospective Review
    Carrillo, Alessandra
    Punatar, Shil
    Pavaluri, Sushma
    Jentink, Madeline
    Patel, Dixita
    Braun, Joseph
    Todorova, Tsvetelina
    Safarpour, Damoun
    Farooqui, Marwah W.
    Ghouse, Masood
    Srinivasan, Krishnan
    BLOOD, 2021, 138
12345